Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRIEND, J. A R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRIEND, J. A R
Topic Collections
Right arrowRelevant Article
Thorax 2001;56:1 ( January )

Editorial

Do smoking parents seek the best advice for their asthmatic children?

The first 150 words of the full text of this article appear below.

In this issue of Thorax a further paper from Dundee is published which explores a group of 438 children aged 2-12 years with asthma. In their first paper1 the authors investigated passive smoke exposure, as measured by salivary cotinine levels, and found that exposure to tobacco smoke was highest where housing conditions were crowded and where several heavy smokers smoked in the same room as the child. In a second paper2 the authors reported that the intervention of asking the parents to reduce the exposure of their asthmatic children to tobacco smoke was ineffective.

The latest paper by Crombie et al3 on page 9 investigates how often the 438 asthmatic children were taken to their family practitioners (GPs), either for asthma or non-asthma problems, and relates this to their smoke exposure. Smoke exposure was assessed both by salivary cotinine levels and also by the history of intensity of exposure as judged by . . . [Full text of this article]

Relevant Article

Does passive smoking increase the frequency of health service contacts in children with asthma?
I K Crombie, A Wright, L Irvine, R A Clark, and P W Slane
Thorax 2001 56: 9-12. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 CMAJHome page
D. E. Low MD
Treatment of community-acquired pneumonia
Can. Med. Assoc. J., December 2, 2008; 179(12): 1245 - 1246.
[Full Text] [PDF]

Home page
 BMJHome page
H. J Durrington and C. Summers
Recent changes in the management of community acquired pneumonia in adults
BMJ, June 21, 2008; 336(7658): 1429 - 1433.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
G. Barlow, D. Nathwani, E. Myers, F. Sullivan, N. Stevens, R. Duffy, and P. Davey
Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia
J. Antimicrob. Chemother., February 1, 2008; 61(2): 442 - 451.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
L. M Bjerre
Management of community acquired pneumonia
BMJ, November 17, 2007; 335(7628): 1004 - 1005.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. Anderson, H. C. Steel, R. Cockeran, A. von Gottberg, L. de Gouveia, K. P. Klugman, T. J. Mitchell, and C. Feldman
Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro
J. Antimicrob. Chemother., November 1, 2007; 60(5): 1155 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Valencia, J. R. Badia, M. Cavalcanti, M. Ferrer, C. Agusti, J. Angrill, E. Garcia, J. Mensa, M. S. Niederman, and A. Torres
Pneumonia Severity Index Class V Patients With Community-Acquired Pneumonia: Characteristics, Outcomes, and Value of Severity Scores
Chest, August 1, 2007; 132(2): 515 - 522.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. K Gorman, R. S Slavik, and J. Marin
Corticosteroid Treatment of Severe Community-Acquired Pneumonia
Ann. Pharmacother., July 1, 2007; 41(7): 1233 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Bont, E. Hak, A. W. Hoes, M. Schipper, F. G. Schellevis, and T. J. M. Verheij
A prediction rule for elderly primary-care patients with lower respiratory tract infections
Eur. Respir. J., May 1, 2007; 29(5): 969 - 975.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G. Barlow, D. Nathwani, and P. Davey
The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia
Thorax, March 1, 2007; 62(3): 253 - 259.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. Anderson, H. C. Steel, R. Cockeran, A. M. Smith, A. von Gottberg, L. de Gouveia, A. Brink, K. P. Klugman, T. J. Mitchell, and C. Feldman
Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae
J. Antimicrob. Chemother., February 1, 2007; 59(2): 224 - 229.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. Abgueguen, E. Azoulay-Dupuis, V. Noel, P. Moine, V. Rieux, B. Fantin, and J.-P. Bedos
Amoxicillin Is Effective against Penicillin-Resistant Streptococcus pneumoniae Strains in a Mouse Pneumonia Model Simulating Human Pharmacokinetics
Antimicrob. Agents Chemother., January 1, 2007; 51(1): 208 - 214.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G. Barlow, D. Nathwani, F. Williams, S. Ogston, J. Winter, M. Jones, P. Slane, E. Myers, F. Sullivan, N. Stevens, et al.
Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis
Thorax, January 1, 2007; 62(1): 67 - 74.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. P. Espana, A. Capelastegui, I. Gorordo, C. Esteban, M. Oribe, M. Ortega, A. Bilbao, and J. M. Quintana
Development and Validation of a Clinical Prediction Rule for Severe Community-acquired Pneumonia
Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1249 - 1256.
[Abstract] [Full Text] [PDF]

Home page
 Fam PractHome page
R M Hopstaken, S Coenen, C C Butler, P Nelemans, J W M Muris, P E L M Rinkens, A D M Kester, and G J Dinant
Prognostic factors and clinical outcome in acute lower respiratory tract infections: a prospective study in general practice
Fam. Pract., October 1, 2006; 23(5): 512 - 519.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Ferech, S. Coenen, S. Malhotra-Kumar, K. Dvorakova, E. Hendrickx, C. Suetens, H. Goossens, and on behalf of the ESAC Project Group
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe
J. Antimicrob. Chemother., August 1, 2006; 58(2): 423 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
S J Bourke
Interstitial lung disease: progress and problems.
Postgrad. Med. J., August 1, 2006; 82(970): 494 - 499.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
R. el Moussaoui, C. A J M de Borgie, P. van den Broek, W. N Hustinx, P. Bresser, G. E L van den Berk, J.-W. Poley, B. van den Berg, F. H Krouwels, M. J M Bonten, et al.
Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
BMJ, June 10, 2006; 332(7554): 1355 - 1355.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
J. Paul
What is the optimal duration of antibiotic therapy?
BMJ, June 10, 2006; 332(7554): 1358 - 1358.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. Nathwani and on behalf of Scottish Medicines Consortium (SMC) S
Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals
J. Antimicrob. Chemother., June 1, 2006; 57(6): 1189 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
Z. Hoare and W. S. Lim
Pneumonia: update on diagnosis and management.
BMJ, May 6, 2006; 332(7549): 1077 - 1079.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. H. Ali, P. Kalima, and S. R. J. Maxwell
Failure to implement hospital antimicrobial prescribing guidelines: a comparison of two UK academic centres
J. Antimicrob. Chemother., May 1, 2006; 57(5): 959 - 962.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Research in NursingHome page
P. Littlejohns and K. Chalkidou
Evidence for health policy
Journal of Research in Nursing, March 1, 2006; 11(2): 110 - 117.
[PDF]

Home page
 BMJHome page
G. D Barlow
Prognostic assessment will be important in flu pandemic.
BMJ, February 25, 2006; 332(7539): 490 - 491.
[Full Text]

Home page
 Eur Respir JHome page
A. Capelastegui, P. P. Espana, J. M. Quintana, I. Areitio, I. Gorordo, M. Egurrola, and A. Bilbao
Validation of a predictive rule for the management of community-acquired pneumonia
Eur. Respir. J., January 1, 2006; 27(1): 151 - 157.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J A Wedzicha, E C Howard, S L Johnston, and D M Mitchell
Thorax Annual Report October 2004-September 2005
Thorax, December 1, 2005; 60(12): 987 - 988.
[Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
G Barlow and D Nathwani
Is antibiotic resistance a problem? A practical guide for hospital clinicians
Postgrad. Med. J., November 1, 2005; 81(961): 680 - 692.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
C.M. McLaughlin, N. Bodasing, A.C. Boyter, C. Fenelon, J.G. Fox, and R.A. Seaton
Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study
QJM, October 1, 2005; 98(10): 745 - 752.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. Menendez, A. Torres, R. Zalacain, J. Aspa, J. J. Martin-Villasclaras, L. Borderias, J. M. Benitez-Moya, J. Ruiz-Manzano, F. R. de Castro, J. Blanquer, et al.
Guidelines for the Treatment of Community-acquired Pneumonia: Predictors of Adherence and Outcome
Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 757 - 762.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Weiss and G. S. Tillotson
The Controversy of Combination vs Monotherapy in the Treatment of Hospitalized Community-Acquired Pneumonia
Chest, August 1, 2005; 128(2): 940 - 946.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
P. Little, K. Rumsby, J. Kelly, L. Watson, M. Moore, G. Warner, T. Fahey, and I. Williamson
Information Leaflet and Antibiotic Prescribing Strategies for Acute Lower Respiratory Tract Infection: A Randomized Controlled Trial
JAMA, June 22, 2005; 293(24): 3029 - 3035.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. Herth, A. Ernst, and H. D. Becker
Endoscopic Drainage of Lung Abscesses: Technique and Outcome
Chest, April 1, 2005; 127(4): 1378 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J A Wedzicha, S L Johnston, and D M Mitchell
Thorax annual report: 1 October 2003 to 30 September 2004
Thorax, December 1, 2004; 59(12): 1012 - 1015.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Paganin, F. Lilienthal, A. Bourdin, N. Lugagne, F. Tixier, R. Genin, and J-L. Yvin
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Eur. Respir. J., November 1, 2004; 24(5): 779 - 785.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. M. Baddour, V. L. Yu, K. P. Klugman, C. Feldman, A. Ortqvist, J. Rello, A. J. Morris, C. M. Luna, D. R. Snydman, W. C. Ko, et al.
Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia
Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 440 - 444.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. J. Harnett, A. P. Fraise, J. M. Andrews, G. Jevons, N. P. Brenwald, and R. Wise
Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492
J. Antimicrob. Chemother., May 1, 2004; 53(5): 783 - 792.
[Abstract] [Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
C Laird, P Driscoll, and J Wardrope
The ABC of community emergency care: 3 Chest pain
Emerg. Med. J., March 1, 2004; 21(2): 226 - 232.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. P. Johnson, C. L. Sheppard, S. J. Harnett, A. Birtles, T. Harrison, N. P. Brenwald, M. J. Gill, R. A. Walker, D. M. Livermore, and R. C. George
Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England
J. Antimicrob. Chemother., December 1, 2003; 52(6): 953 - 960.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Midulla, J. de Blic, A. Barbato, A. Bush, E Eber, S Kotecha, E Haxby, C Moretti, P Pohunek, and F Ratjen
Flexible endoscopy of paediatric airways
Eur. Respir. J., October 1, 2003; 22(4): 698 - 708.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Ewig and A. Torres
Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?
Eur. Respir. J., May 1, 2003; 21(5): 741 - 742.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. Nathwani
From evidence-based guideline methodology to quality of care standards
J. Antimicrob. Chemother., May 1, 2003; 51(5): 1103 - 1107.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
T.J. Marrie
Coxiella burnetii pneumonia
Eur. Respir. J., April 1, 2003; 21(4): 713 - 719.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. M. Luna
Blood Cultures in Community-Acquired Pneumonia: Are We Ready To Quit?
Chest, April 1, 2003; 123(4): 977 - 978.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
G. Gopal Rao, C. S. Mahankali Rao, and I. Starke
Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with {beta}-lactam-based therapy
J. Antimicrob. Chemother., March 1, 2003; 51(3): 697 - 701.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02)
Evid. Based Nurs., January 1, 2003; 6(1): e1 - 1.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Woodhead
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Eur. Respir. J., July 1, 2002; 20(36_suppl): 20S - 27s.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S V Baudouin
The pulmonary physician in critical care 3: Critical care management of community acquired pneumonia
Thorax, March 1, 2002; 57(3): 267 - 271.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 BMJ Publishing Group Ltd & British Thoracic Society